SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : MedImmune
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Shlepper who wrote (118)6/19/1998 2:32:00 PM
From: vedia  Read Replies (1) of 416
 
MEDI halted at 2:17PM . Anyone know why?

UPDATE:

14:30 ET MedImmune Inc (MEDI) 56 -3/4 (halted): FDA gives thumbs up on Synagis, a treatment for respiratory syncytial virus (RSV) disease in high-risk infants. RSV is the most common cause of pneumonia and bronchiolitis in infants and children. MEDI shares have risen approx. 10 pts since the beginning of the week.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News